We aim to create an inspiring environment in which outstanding scientists can excel. By providing state-of-the-art core facilities and support for our researchers, we foster new collaborations that spark discoveries about fundamental cellular processes and their relevance in disease.
In Traffic, the Deane lab have revealed a new cell biological framework for pathogenesis of the fatal neurodegenerative disorder Krabbe Disease, by characterizing a series of disease mutations in the lysosomal enzyme galactocerebrosidase (GALC).
Alan Warren will receive a FEBS National Lecture Award at the Austrian Society for Molecular Biology and Biotechnology annual meeting in September. These awards, established to commemorate the 40th anniversary of FEBS, recognize the achievements of distinguished scientists.